Last reviewed · How we verify
Oral typhoid fever vaccine
Oral typhoid fever vaccine is a Biologic drug developed by Helsinki University Central Hospital. It is currently FDA-approved. Also known as: Vivotif®.
At a glance
| Generic name | Oral typhoid fever vaccine |
|---|---|
| Also known as | Vivotif® |
| Sponsor | Helsinki University Central Hospital |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Blood Donor CVD 5000 (PHASE4)
- Vaccine- and Infection-derived Correlates of Protection for Cholera. (NA)
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (PHASE3)
- CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults (PHASE4)
- Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women (NA)
- Induction of Gut Permeability by an Oral Vaccine (EARLY_PHASE1)
- Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine (PHASE1)
- Infant Malaria Vaccine Schedule Optimization (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral typhoid fever vaccine CI brief — competitive landscape report
- Oral typhoid fever vaccine updates RSS · CI watch RSS
- Helsinki University Central Hospital portfolio CI
Frequently asked questions about Oral typhoid fever vaccine
What is Oral typhoid fever vaccine?
Oral typhoid fever vaccine is a Biologic drug developed by Helsinki University Central Hospital.
Who makes Oral typhoid fever vaccine?
Oral typhoid fever vaccine is developed and marketed by Helsinki University Central Hospital (see full Helsinki University Central Hospital pipeline at /company/helsinki-university-central-hospital).
Is Oral typhoid fever vaccine also known as anything else?
Oral typhoid fever vaccine is also known as Vivotif®.
What development phase is Oral typhoid fever vaccine in?
Oral typhoid fever vaccine is FDA-approved (marketed).
Related
- Manufacturer: Helsinki University Central Hospital — full pipeline
- Also known as: Vivotif®
- Compare: Oral typhoid fever vaccine vs similar drugs
- Pricing: Oral typhoid fever vaccine cost, discount & access